Cognoptix, a privately held medical technology company headquartered in Acton, Mass., is focused on developing and commercializing an in-office, drug/device diagnostic system as an aid in the early detection of Alzheimer\'s Disease (AD). Its investors include Alopexx Enterprises, Inventages Venture Capital, and Launchpad Venture Group.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/01/14 | $15,000,000 | Series C |
Alopexx Enterprises Inventages Launchpad Venture Group | undisclosed |
| 09/28/20 | $2,600,000 | Series R |
Launchpad Venture Group New York Angels | undisclosed |
